All articles by Jangoulun Singsit

Jangoulun Singsit

Eisai’s anti-cancer agent LENVIMA receives orphan drug designation

Japanese pharmaceutical company Eisai has received orphan drug designation for its anti-cancer agent LENVIMA with a prospective indication for uterine body cancer.

EU countries suspend use of Covid-19 vaccine AstraZeneca

Several countries in Europe have suspended the University of Oxford / AstraZeneca (AZ) Covid-19 vaccine completely or partially after several suspected deaths were reported due to blood clotting following vaccination.